Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia

被引：0
|
作者：
Wei, Zhichen [1 ]
Shao, Linlin [1 ]
Xu, Shuqian [1 ]
Zhang, Xiaolin [1 ]
Wang, Lin [1 ]
Qin, Ping [1 ]
Song, Qiang [1 ]
Hou, Ming [1 ,2 ]
Shi, Yan [1 ]
机构：
[1] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Peoples R China
[2] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Shandong Prov Key Lab Immunohematol, Jinan, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
acute myeloid leukemia; acute promyelocytic leukemia; all-trans retinoic acid; nucleoporin 98-retinoic acid receptor gamma; azacitidine; RETINOIC ACID; FUSION;
D O I：
10.3389/fonc.2024.1460557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We report a case of acute myeloid leukemia (AML) with retinoic acid receptor gamma (RARG) rearrangement, exhibiting clinical, morphological, and immunophenotypic features similar to classic acute promyelocytic leukemia (APL). RNA sequencing analysis of the patient's bone marrow samples revealed the presence of nucleoporin 98 (NUP98)-RARG caused by translocation. AML with RARG rearrangement is insensitive to all-trans retinoic acid (ATRA) and arsenic trioxide. The patient received azacitidine therapy after failing ATRA and standard 3 + 7 therapy (idarubicin and cytarabine) and achieved complete remission. Conclusively, this acute myeloid leukemia subtype may benefit from azacitidine.
引用
收藏
页数：6
相关论文
共 50 条
  • [31] REARRANGED NUP98 IN ACUTE MYELOID LEUKEMIA IN CHILDHOOD. GENETIC CHARACTERISTICS AND PREDICTIVE VALUE
    Kalinina, I.
    Venyov, D.
    Zerkalenkova, E.
    Gaskova, M.
    Olshanskaya, Yu.
    Voronin, K.
    Novichkova, G.
    Maschan, M.
    Maschan, A.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S44 - S44
  • [32] Clinical Characteristics and Outcomes of NUP98 Rearrangement in Adults with Acute Leukemia
    Klein, Katherine
    Kantarjian, Hagop
    Farhat, Aziz
    Sasaki, Koji
    Short, Nicholas
    Bidikian, Aram
    Loghavi, Sanam
    Patel, Keyur
    Tang, Guilin
    Yilmaz, Musa
    Montalban-Bravo, Guillermo
    Hammond, Danielle
    Pemmaraju, Naveen
    Daver, Naval
    DiNardo, Courtney
    Pierce, Sherry
    Jabbour, Elias
    Kadia, Tapan
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Cuglievan, Branko
    Issa, Ghayas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S334 - S335
  • [33] Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia
    Zompi, S
    Viguié, F
    LEUKEMIA & LYMPHOMA, 2002, 43 (02) : 275 - 280
  • [34] Myeloid natural killer cell leukemia resembling a variant of acute promyelocytic leukemia
    Burgaleta, C
    de Miguel, D
    Rubio, ML
    Krsnik, I
    Suárez, JG
    HAEMATOLOGICA, 2001, 86 (07) : 765 - 766
  • [35] Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study
    Heald, James S.
    Lopez, Aleix Mendez
    Pato, Miguel L.
    Ruiz-Xiville, Neus
    Cabezon, Marta
    Zamora, Lurdes
    Vives, Susana
    Coll, Rosa
    Maluquer, Clara
    Granada, Isabel
    Sole, Francesc
    Esteller, Manel
    Berdasco, Maria
    BLOOD ADVANCES, 2024, 8 (11) : 2691 - 2694
  • [36] Acute Myeloid Leukemia with NUP98 Rearrangement and Partner Genes Detected by Using RNA Fusion Panel
    Frerich, C.
    Xie, W.
    Hoyos, C. Magallanes
    Press, R.
    Li, P.
    Mohebnasab, M.
    Dunlap, J.
    Raess, P.
    Fan, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S45 - S45
  • [37] Loss of heterozygosity (LOH) of the NUP98 gene is an adverse prognostic factor in acute myeloid leukemia (AML).
    Plasilova, Magdalena
    Ommen, Hans B.
    Jelinek, Jaroslav
    Issa, Jean-Pierre
    Riedel, Elyn R.
    Mathew, Susan
    Chadburn, Amy
    Zhou, Pengbo
    Hokland, Peter
    Moore, Malcolm A. S.
    BLOOD, 2006, 108 (11) : 668A - 668A
  • [38] Monitoring measurable residual disease in NUP98::NSD1-positive acute myeloid leukemia
    Okuchi, Ikuo
    Nishimura, Akira
    Kamiya, Takahiro
    Sasaki, Makiko
    Yamashita, Motoi
    Hoshino, Akihiro
    Kajiwara, Michiko
    Isoda, Takeshi
    Kanegane, Hirokazu
    Morio, Tomohiro
    Takagi, Masatoshi
    PEDIATRICS INTERNATIONAL, 2025, 67 (01)
  • [39] CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia
    Schmoellerl, Johannes
    Barbosa, Ines Amorim Monteiro
    Eder, Thomas
    Brandstoetter, Tania
    Schmidt, Luisa
    Maurer, Barbara
    Troester, Selina
    Pham, Ha Thi Thanh
    Sagarajit, Mohanty
    Ebner, Jessica
    Manhart, Gabriele
    Aslan, Ezgi
    Terlecki-Zaniewicz, Stefan
    Van der Veen, Christa
    Hoermann, Gregor
    Duployez, Nicolas
    Petit, Arnaud
    Lapillonne, Helene
    Puissant, Alexandre
    Itzykson, Raphael
    Moriggl, Richard
    Heuser, Michael
    Meisel, Roland
    Valent, Peter
    Sexl, Veronika
    Zuber, Johannes
    Grebien, Florian
    BLOOD, 2020, 136 (04) : 387 - 400
  • [40] First Case Report of the NUP98-SETBP1 Fusion Gene in Therapy Related Acute Myeloid Leukemia
    Kawamura, Machiko
    Haruta, Masayuki
    Kaneko, Yasuhiko
    PEDIATRIC BLOOD & CANCER, 2021, 68
12345